Early Toxicology Testing Market 2022 Top Vendors, Regions, Opportunity, Technology Progress, Market Dynamics

Global Early Toxicity Testing Market was $614 million and is estimated to reach $1,012 million by 2022, registering a CAGR of 7.3% from 2016 to 2022. Toxins are substances that can adversely affect living organisms. They are present in a variety of products such as food additives, chemicals, pesticides, and cosmetics. During drug development, it was observed that approximately 26% of the products face rejection in the later stages of development due to safety issues.

This leads to massive financial losses for many industries, which include pharmaceuticals and food industries. To avoid the financial losses, early toxicity tests are used to remove the toxic component in the product and reduce the risk of late-stage failure. Different types of toxic tests such as acute toxicity tests, neurotoxicity, systemic toxicity, and carcinogenicity are conducted using in vivo and in vitro techniques. These toxicity tests help the companies provide proofs to the regulatory bodies that they are safe for humans and will not adversely affect human health.

The key players profiled in this report include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies Inc., Quest Diagnostics Incorporation, Merck & Co., Inc., Charles River Laboratories International Incorporation, Becton, Dickinson And Company, Danaher Corporation, Evotec Ag, and The Jackson Laboratory.

There are other players in the early toxicity testing market which include Covance, CellSystems, BioQuanta, Epithelix, Celther Polska, and HemoGenix.

Get Discount UP To 25% on this Report * Offer Till 31st Dec 2018 at : https://www.alliedmarketresearch.com/checkout/432965

Asia-Pacific possesses high market potential for growth of early toxicity testing due to increase in demand for toxicity tests and upsurge in governmental initiatives to protect public health and environment. Progress in the research of in vitro and in silico technique has led to rapid developments in the toxicity testing products.

Early toxicity testing market in India is projected to grow at a high CAGR of 13.2% during the forecast period. Asia-Pacific is experiencing fast-paced growth in terms of production and development of early toxicity testing products.

The global early toxicity testing market is segmented based on technique, end users, and geography. Based on technique, the market is categorized into in vivo, in vitro, and in silico. Based on the type of assay used, in vitro technique is further divided into enzyme toxicity assays, bacterial toxicity assays, cell-based ELISA and western blots, tissues culture assays, receptor binding assays, and other assays. Based on the toxicity end-points, in vitro technique is further segmented into dermal toxicity, systemic toxicity, carcinogenicity, ocular toxicity, skin sensitization and irritation, genotoxicity, neurotoxicity, organ toxicity, and other toxicity endpoints. Based on end-users, the market is segmented into pharmaceuticals industry, diagnostics industry, food industry, chemicals industry, cosmetics industry, and other industries. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

The market is expected to witness moderate growth during the forecast period, owing to the increase in awareness of the regulatory authorities concerning environment and public health welfare. In addition, replacement of in vivo models with in vitro models and technological advancement in the in vitro and in vivo technique supplement the market growth. As early toxicity tests can help reduce the risk of drug failure in later stages, there is a rise in the demand for early toxicity tests. This has increased investment in the R&D for these products, which help boost the market growth. However, limited awareness about the benefits of early toxicity testing and limitations of preclinical testing are expected to hamper the market growth.

Key Benefits

• This report entails detailed quantitative analysis of the current market trends for the period of 2014-2022 to identify the prevailing opportunities.
• The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
• The global early toxicity testing market is comprehensively analyzed with respect to technique, end users, and geography.
• In-depth analysis based on geography helps understand the regional market to assist in strategic business planning.
• The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.